Joham Anju E, Tay Chau Thien, Laven Joop, Louwers Yvonne V, Azziz Ricardo
Monash Centre for Health Research and Implementation, Faculty of Medicine Nursing and Health Sciences, Monash University, Clayton 3168, Australia.
Departments of Diabetes and Endocrinology, Monash Health, Clayton 3168, Australia.
J Clin Endocrinol Metab. 2025 Jun 17;110(7):e2298-e2308. doi: 10.1210/clinem/dgae910.
Polycystic ovary syndrome (PCOS) affects 10% to 13% of women globally. It is a condition with metabolic, reproductive, and psychological features, with health impacts across the lifespan. The etiology of PCOS is complex, with an interplay of several factors, including genetic and epigenetic susceptibility, androgen exposure in early life and adiposity-related dysfunction leading to hypothalamic-ovarian disturbance. Diagnosis is recommended based on the International PCOS Guideline criteria, with diagnosis confirmed in adults when 2 of out the following 3 criteria are met: (i) hyperandrogenism (clinical or biochemical); (ii) irregular cycles; and (iii) polycystic ovary morphology or elevated anti-Müllerian hormone (AMH) levels. With its clinical heterogeneity, distinct phenotypes, variation across the lifespan and ethnic variation, PCOS diagnosis can present significant diagnostic challenges to clinicians.
多囊卵巢综合征(PCOS)影响着全球10%至13%的女性。它是一种具有代谢、生殖和心理特征的病症,对整个生命周期的健康都会产生影响。PCOS的病因复杂,多种因素相互作用,包括遗传和表观遗传易感性、早年雄激素暴露以及与肥胖相关的功能障碍导致下丘脑 - 卵巢紊乱。建议根据国际PCOS指南标准进行诊断,在成人中,当满足以下3项标准中的2项时诊断成立:(i)高雄激素血症(临床或生化);(ii)月经周期不规律;(iii)多囊卵巢形态或抗苗勒管激素(AMH)水平升高。由于其临床异质性、不同的表型、生命周期各阶段的变化以及种族差异,PCOS诊断可能给临床医生带来重大的诊断挑战。